Owen Wallace to Transition to Scientific Advisory Board Owen Wallace to Transition to Scientific Advisory Board

Go here to read the rest:
Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh